2023 Form 5500 filing — Ionis Pharmaceuticals 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240919145528NAL0012966466001) for Ionis Pharmaceuticals 401(K) Plan, reported by Ionis Pharmaceuticals, Inc. under EIN 33-0336973 and plan number 001. It reports 1,202 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20240919145528NAL0012966466001
Filing year
2023
Form type
2
Plan sponsor
Ionis Pharmaceuticals, Inc.
EIN
33-0336973
Plan number
001
Location
Carlsbad, CA
Participants
1,202
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$254,811,590
Total liabilities (EOY)
$0
Net assets (EOY)
$254,811,590
Employer contributions
$7,607,127
Participant contributions
$15,450,122
Total income / additions
$72,369,671
Benefits paid
$12,596,675
Administrative expenses
$4,992
Total expenses
$12,610,219
Net increase / (decrease)
$59,759,452
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
First Light Retirement LLCADVISOR$104,796not reported in the loaded dataset
Fidelity Investments InstitutionalRECORDKEEPER-$99,771$0

Related Form 5500 pages